PAVmed Launches Veris Cancer Care Platform with Ohio State University for Enhanced Patient Monitoring

PAVmed Unveils Veris Cancer Care Platform in Collaboration with Ohio State University Comprehensive Cancer Center

PAVmed Inc. (Nasdaq: PAVM), a diversified medical technology enterprise, announces the commercial launch of its Veris Cancer Care Platform in collaboration with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). This strategic partnership marks a significant advancement in personalized cancer care, particularly for patients undergoing systemic therapies. The Veris Cancer Care Platform is designed to enhance patient outcomes through real-time monitoring and data collection, thereby transforming how cancer care is administered.

The Veris Cancer Care Platform represents an innovative approach to managing complex cancer treatments. By integrating remote physiological data collection, symptom reporting, and telehealth capabilities, the platform allows healthcare providers to monitor patients' health trajectories closely. This comprehensive digital solution not only facilitates early detection of potential complications but also aims to minimize unplanned hospitalizations. Patients enrolled in the program receive a VerisBox™, equipped with connected health devices that relay crucial health data to a cloud-based clinician portal, ensuring continuous oversight by healthcare professionals.

Moreover, the platform includes a complementary patient portal accessible via a smartphone app. This feature enables patients to report symptoms and monitor health parameters while keeping family members and caregivers informed about their care journey. The partnership further extends to the establishment of a clinical registry for patients utilizing the platform, enhancing OSUCCC – James's ability to engage with patients beyond conventional healthcare settings. Dr. David Cohn, COO and CMO at The James Cancer Hospital, underscores the significance of this collaboration, affirming their dedication to delivering personalized cancer care and paving the way for innovative treatment methodologies.

In addition to this launch, PAVmed's commitment to advancing medical technology is evident in its focus on integrating digital health solutions within cancer care. The Veris Cancer Care Platform is positioned to play a crucial role in the evolution of oncology, providing healthcare providers with valuable insights that could lead to better patient care strategies.

This partnership not only signifies a leap forward for PAVmed but also contributes to the broader medical technology landscape, emphasizing the importance of personalized treatment in oncology. As the healthcare industry increasingly embraces digital transformation, PAVmed’s innovative approach could set a new standard for cancer care delivery.